Skip to main content
. 2023;24(2):102–109. doi: 10.22099/IJVR.2023.42877.6230

Table 3.

Mean±SD of heart rate (HR), mean arterial pressure (MAP), and respiratory rate (fR) in anesthetized dogs (n=6) received ketofol (KET), and ketofol plus lidocaine (KLD), fentanyl (KFN) or dexmedetomidine (KDX)

Variable Treatment Time (min)
Baseline 5 15 30 45 60
HR (beats/min) KET 59±10 110±24A, a 119±29A, a 106±14A, a 100±18A, a 107±16A, a
KLD 60±8 122±18A, B, a 124±15A, B, a 125±7A, B, a 127±8B, a 116±13A, B, a
KFN 75±14 62±13B 56±19B 57±19B 51±8B 58±8B
KDX 68±4 55±4B, a 48±6B 47±8B, a 49±7B, a 50±4B, a
MAP (mmHg) KET 87±7 95±25A, B 96±29 99±33 100±32 96±21A, B
KLD 91±26 77±19B 81±24 83±22 71±13 70±13B
KFN 101±4 92±4B 95±6 94±3 89±1 90±2A, B
KDX 75±10 114±6A, a 109±9a 105±8a 101±8a 99±10A, a
f R (breaths/min) KET 15±2 10±3A 10±4A 9±3A 8±3 9±3
KLD 12±4 11±7A 10±5A 7±1A 6±1 6±1
KFN 17±4 4±4a 5±2a 4±1a 7±3a 9±7
KDX 15±3 5±1a 4±1a 5±2a 6±3a 7±3

Different uppercases indicate significant differences among treatments (P<0.05), and different lowercases indicate significant differences from baseline (P<0.05)